Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response. - Kleczko EK; Le AT; Hinz TK; Nguyen TT; Navarro A; Hu CJ; Selman AM; Clambey ET; Merrick DT; Lu S; Weiser-Evans M; Nemenoff RA; et al. (Cancer letters, 2023)